CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,926,645 | -19.0% | 251,695 | -0.1% | 2.67% | -13.4% |
Q2 2023 | $8,546,800 | -5.9% | 251,895 | -0.2% | 3.08% | -6.0% |
Q1 2023 | $9,081,173 | -24.5% | 252,395 | -6.5% | 3.28% | -27.1% |
Q4 2022 | $12,029,225 | +60.1% | 269,895 | +1.0% | 4.50% | +42.0% |
Q3 2022 | $7,514,000 | +4.6% | 267,295 | +0.3% | 3.17% | +12.0% |
Q2 2022 | $7,186,000 | -21.6% | 266,545 | -0.9% | 2.83% | -8.6% |
Q1 2022 | $9,164,000 | -6.5% | 269,045 | +6.1% | 3.10% | -5.5% |
Q4 2021 | $9,803,000 | -33.1% | 253,696 | -6.5% | 3.27% | -34.6% |
Q3 2021 | $14,654,000 | +28.9% | 271,429 | -20.2% | 5.00% | +33.9% |
Q2 2021 | $11,367,000 | +53.6% | 339,929 | -5.4% | 3.74% | +43.2% |
Q1 2021 | $7,400,000 | +4.7% | 359,229 | -10.9% | 2.61% | +3.9% |
Q4 2020 | $7,065,000 | +7.8% | 403,229 | -8.7% | 2.51% | -6.3% |
Q3 2020 | $6,551,000 | +37.0% | 441,729 | +20.0% | 2.68% | +31.2% |
Q2 2020 | $4,783,000 | +602.3% | 367,961 | -10.3% | 2.04% | +430.6% |
Q1 2020 | $681,000 | -14.4% | 410,017 | +14.9% | 0.38% | +13.6% |
Q4 2019 | $796,000 | +127.4% | 356,890 | +117.4% | 0.34% | +93.7% |
Q3 2019 | $350,000 | -15.9% | 164,142 | +5.8% | 0.18% | -9.3% |
Q2 2019 | $416,000 | -46.0% | 155,081 | -0.9% | 0.19% | -49.6% |
Q1 2019 | $770,000 | – | 156,414 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |